40 results
8-K
EX-99.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results
4:05pm
in personnel-related expenses due to reduced headcount and the higher bonus and severance amounts paid in 2022, and $0.3 million in professional fees
8-K
EX-1.1
1j9 ufvev
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-99.1
di5x7l r2l
10 May 22
UNITY Biotechnology, Inc. Reports First Quarter 2022
4:01pm
PRE 14A
2gji3q1nvwpof
12 Apr 22
Preliminary proxy
4:02pm
8-K
7m5u 43xg
14 Dec 20
UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore O’Neill, M.B., to the Board of Directors
4:17pm